For decades, the journey with Multiple Sclerosis (MS) has been framed as a battle of attrition—a slow, managed decline against an unyielding foe. The narrative has been one of adaptation, of learning to live with the progressive erosion of self, as the body’s own defense system tragically turns inward. But what if this entire narrative is outdated? What if the goal wasn’t just to manage the decay, but to execute a fundamental reset of the very system that fuels the disease?
This isn’t a conversation about incremental improvements or another medication to mask symptoms. This is a paradigm shift. We are here to discuss the profound potential of advanced stem cell therapy not as a treatment, but as a biological reboot—a method to halt the progression of MS and reclaim the body’s immunological sanity. For those who feel they are losing ground in a defensive war, it’s time to explore the science of going on the offensive.
Imagine your immune system is a highly sophisticated computer operating system. In a healthy individual, this system runs flawlessly, identifying and neutralizing threats with precision. In a person with MS, this operating system has been corrupted by a deeply embedded virus. It’s not just one or two files that are bad; the core programming is flawed, causing it to attack its own hardware.
You can run antivirus software (immunosuppressive drugs), which might slow the virus down, but it continues to run in the background, causing damage. AHSCT is the equivalent of a complete system wipe and reinstallation of the original, uncorrupted factory settings.
While aHSCT is the powerful reboot, another type of cell offers a complementary and crucial role: Mesenchymal Stem Cells (MSCs). If aHSCT is the system reinstallation, MSCs are the crisis-response team and master regulators. Harvested from sources like umbilical cord tissue, these cells possess a remarkable and distinct intelligence.
MSCs have a powerful paracrine effect, meaning they release a cascade of bioactive molecules that act as signals to other cells. They are powerfully anti-inflammatory, capable of calming the fires of an autoimmune attack. But their true “wow” factor lies in their immunomodulatory capacity. They don’t just suppress the immune system; they intelligently regulate it. They can promote the activity of regulatory T-cells (Tregs), which act as peacekeepers, telling other immune cells to stand down.
Science this profound demands more than just a state-of-the-art laboratory; it requires an ecosystem of healing. The most advanced protocols can fall short if delivered in a cold, impersonal, or fragmented system. This is where the strategic choice of location becomes a critical component of the treatment’s success. This is why the team at Regencord is anchored in Pereira, Colombia.
We have consciously built a center of excellence that redefines the very concept of medical travel. This isn’t about finding a cheaper alternative; it’s about seeking a superior one. The “Pereira Advantage” is a synergy of three core principles:
Trust is built on transparency. Through our consultations, we hear the same crucial questions, born from a mix of hope and fear. We believe in addressing these head-on.
This is, without question, the most important question to address. The primary, scientifically validated goal of advanced cell therapy like aHSCT is to halt the progression of the disease. It is designed to stop future attacks and prevent further disability from accumulating. While some patients do experience a modest improvement in their symptoms—often due to the reduction of systemic inflammation—it is crucial to understand that this is not a therapy to repair long-standing nerve damage. The myelin and nerve cells that have been lost over years cannot be regrown with this procedure. The “miracle” here is not the reversal of the past, but the opportunity to secure a future free from the relentless advancement of MS. We are here to help you draw a line and move forward, not to rewrite history.
Autologous therapy (aHSCT) uses your own hematopoietic stem cells to reboot your immune system. It is a powerful, one-time procedure. Allogeneic therapy, as we practice it with Mesenchymal Stem Cells (MSCs), uses cells from a healthy, screened donor (typically umbilical cord tissue). MSCs are not for rebooting the immune system, but for powerfully regulating inflammation and modulating the immune response on an ongoing basis. The best approach depends on your specific MS type, disease activity, and overall health.
Based on extensive global research, the ideal candidate typically has a highly active, relapsing-remitting form of MS (RRMS), is under the age of 50, has had MS for less than 10-15 years, and continues to have relapses or new MRI activity despite treatment with high-efficacy disease-modifying therapies. It is generally less effective for those with advanced progressive MS who no longer show active inflammation.
The chemotherapy is a serious and intensive part of the treatment. Short-term risks include infection (while your immune system is down), nausea, hair loss, and fatigue. There is also a long-term risk of infertility, which is a critical consideration for younger patients. Our protocol includes comprehensive pre-treatment evaluation and post-treatment support to manage these risks effectively.
Following the stem cell infusion, it takes several weeks for the new immune system to begin populating. The initial period requires careful monitoring in a controlled environment to prevent infection. Most patients begin to feel a significant return of energy within 3-6 months, though the full reconstitution of the immune system can take up to a year.
While aHSCT is performed in some centers in the US and Europe, it is often restricted by very narrow criteria or accessible only through long-term clinical trials. Furthermore, the holistic, integrated approach that combines globally-leading lab science with a dedicated healing environment and seamless patient support is a model of care the team at Regencord has specifically pioneered. Many patients choose our center not just for access, but for the superior, comprehensive nature of our program.
Our on-site, dedicated laboratory is the heart of our operation. We do not use outside labs. This gives us complete control over the entire process, from cell characterization and purification to ensuring potency and sterility. This closed-loop system minimizes the risk of contamination and guarantees that the cellular product you receive meets our exacting standards, which are aligned with the highest international benchmarks.
The first step is a no-obligation, comprehensive medical review and consultation. Our team will review your complete medical history, MRI reports, and previous treatments to provide an honest and thorough assessment of whether our therapies are a suitable option for you. We believe in empowering patients with information, whether they choose to proceed with us or not.
The team at Regencord is a collective of scientists, clinicians, and patient advocates united by a single mission: to deliver the most advanced and compassionate regenerative medicine available today. From our center of excellence in Pereira, Colombia, we are dedicated to shifting the paradigm of chronic disease treatment. We believe that true healing emerges from the synergy of uncompromising scientific rigor, a deep commitment to patient partnership, and an environment that fosters genuine well-being. This guide was created as part of that commitment—to provide clear, authoritative, and hype-free information to empower you on your health journey.
Disclaimer: The information provided by the team at Regencord is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reliance on any information provided in this article is solely at your own risk.
We focus on knee treatment using stem cell therapy, focusing on three main processes:
Stem cells are unique cells with the ability to develop into various cell types and repair damaged tissues. They are used in regenerative medicine, including treatments for cancer, neurodegenerative diseases, and injuries. Sources include bone marrow, cord blood, and embryos.
+1 888-540-4101
